Dr. Anas Tomeh is a research and development scientist for Labcorp Early Development. His background is in pharmaceutical technology and development of nanoformulations for drug and gene delivery.
In his role, Anas focuses on the preparation of nanoparticle formulations as well as the development of methods for characterizing biopharmaceutical products such as vaccines and antigen formulations. He is currently working on developing new efficient mRNA-lipid nanoparticles as vaccines for enhanced immune response.